These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6378697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE, Abram JD, Frank BH, Duckworth WC.
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [Abstract] [Full Text] [Related]

  • 4. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H, Tsuji A, Hirai K, Kang YS.
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI, Buynitzky SJ, Almira EC.
    Drug Metab Dispos; 1982 May; 10(2):153-5. PubMed ID: 6124401
    [Abstract] [Full Text] [Related]

  • 11. B1-3,5-diiodotyrosine insulin: a valid tracer for insulin.
    Ellis MJ, Jones RH, Thomas JH, Geiger R, Teetz V, Sönksen PH.
    Diabetologia; 1977 May; 13(3):257-61. PubMed ID: 873092
    [Abstract] [Full Text] [Related]

  • 12. Biological potency and binding affinity of monoiodoinsulin with iodine in tyrosine A14 or tyrosine A19.
    Gliemann J, Sonne O, Linde S, Hansen B.
    Biochem Biophys Res Commun; 1979 Apr 27; 87(4):1183-90. PubMed ID: 465032
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS, Jones RH, Sönksen PH.
    Diabet Med; 1985 Jul 27; 2(4):241-4. PubMed ID: 2951075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S, Sonne O, Hansen B, Gliemann J.
    Hoppe Seylers Z Physiol Chem; 1981 Jun 27; 362(6):573-9. PubMed ID: 7024083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
    Navalesi R, Pilo A, Ferrannini E.
    J Clin Invest; 1978 Jan 27; 61(1):197-208. PubMed ID: 338630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.